OX40 is a potent immune-stimulating target in late-stage cancer patients.

Abstract:

:OX40 is a potent costimulatory receptor that can potentiate T-cell receptor signaling on the surface of T lymphocytes, leading to their activation by a specifically recognized antigen. In particular, OX40 engagement by ligands present on dendritic cells dramatically increases the proliferation, effector function, and survival of T cells. Preclinical studies have shown that OX40 agonists increase antitumor immunity and improve tumor-free survival. In this study, we performed a phase I clinical trial using a mouse monoclonal antibody (mAb) that agonizes human OX40 signaling in patients with advanced cancer. Patients treated with one course of the anti-OX40 mAb showed an acceptable toxicity profile and regression of at least one metastatic lesion in 12 of 30 patients. Mechanistically, this treatment increased T and B cell responses to reporter antigen immunizations, led to preferential upregulation of OX40 on CD4(+) FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, and increased the antitumor reactivity of T and B cells in patients with melanoma. Our findings clinically validate OX40 as a potent immune-stimulating target for treatment in patients with cancer, providing a generalizable tool to favorably influence the antitumor properties of circulating T cells, B cells, and intratumoral regulatory T cells.

journal_name

Cancer Res

journal_title

Cancer research

authors

Curti BD,Kovacsovics-Bankowski M,Morris N,Walker E,Chisholm L,Floyd K,Walker J,Gonzalez I,Meeuwsen T,Fox BA,Moudgil T,Miller W,Haley D,Coffey T,Fisher B,Delanty-Miller L,Rymarchyk N,Kelly T,Crocenzi T,Bernstein E,

doi

10.1158/0008-5472.CAN-12-4174

subject

Has Abstract

pub_date

2013-12-15 00:00:00

pages

7189-7198

issue

24

eissn

0008-5472

issn

1538-7445

journal_volume

73

pub_type

杂志文章
  • The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.

    abstract::DNA damage inactivates cyclin-dependent kinases (CDKs) and arrests the cell cycle. Following DNA damage, the G1-S CDKs are inhibited by a mechanism involving p53-dependent induction of p21Cip1/Waf1; but how the Cdc2 is inhibited is less apparent. We found that the signal generated by the DNA damage checkpoint in G2 wa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Poon RY,Chau MS,Yamashita K,Hunter T

    更新日期:1997-11-15 00:00:00

  • Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.

    abstract::Alterations in expression of or responsiveness to transforming growth factor beta (TGF-beta) are frequently found in human and animal epithelial cancers and are though to be important for loss of growth control in the neoplastic cell. We show here that keratinocyte cell lines from mice with a targeted deletion of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Glick AB,Weinberg WC,Wu IH,Quan W,Yuspa SH

    更新日期:1996-08-15 00:00:00

  • Immunohistological analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium.

    abstract::PE-35 mouse monoclonal antibody (MoAb) (IgG1) detecting an epithelial antigen with a molecular weight of 35,000 was characterized serologically. Immunoperoxidase staining and double immunoenzymatic staining showed that PE-35 antigen is predominantly on nonlymphoid cells in the medulla of thymus. By immunoelectron micr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takahashi T,Ueda R,Nishida K,Namikawa R,Fukami H,Matsuyama M,Masaoka A,Imaizumi M,Takahashi T

    更新日期:1988-04-01 00:00:00

  • Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.

    abstract::Monoclonal antibody B72.3, reactive with a high-molecular-weight glycoprotein tumor-associated antigen (designated TAG-72), has been previously shown to be reactive with formalin-fixed paraffin-embedded tissue sections of adenocarcinomas of the ovary, colon, and breast and not a variety of normal adult tissues. It has...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Johnston WW,Szpak CA,Thor A,Schlom J

    更新日期:1986-12-01 00:00:00

  • The signatures of autozygosity among patients with colorectal cancer.

    abstract::Previous studies have shown that among populations with a high rate of consanguinity, there is a significant increase in the prevalence of cancer. Single nucleotide polymorphism (SNP) array data (Affymetrix, 50K XbaI) analysis revealed long regions of homozygosity in genomic DNAs taken from tumor and matched normal ti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5250

    authors: Bacolod MD,Schemmann GS,Wang S,Shattock R,Giardina SF,Zeng Z,Shia J,Stengel RF,Gerry N,Hoh J,Kirchhoff T,Gold B,Christman MF,Offit K,Gerald WL,Notterman DA,Ott J,Paty PB,Barany F

    更新日期:2008-04-15 00:00:00

  • The role of hMLH3 in familial colorectal cancer.

    abstract::Hereditary nonpolyposis colorectal cancer (HNPCC) is commonly associated with at least three currently known DNA mismatch repair genes: (a) hMSH2; (b) hMLH1; and (c) hMSH6. A majority of HNPCC families has identifiable mutations in hMLH1 and hMSH2. When these mutations cause an inherited risk of colorectal cancer, the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu HX,Zhou XL,Liu T,Werelius B,Lindmark G,Dahl N,Lindblom A

    更新日期:2003-04-15 00:00:00

  • TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.

    abstract::Breast cancers expressing estrogen receptor-alpha (ERalpha) are associated with a favorable biology and are more likely to respond to hormonal therapy. In addition to ERalpha, other pathways of estrogen response have been identified including ERbeta and GPR30, a membrane receptor for estrogen, and the key mechanisms r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2293

    authors: Woodfield GW,Horan AD,Chen Y,Weigel RJ

    更新日期:2007-09-15 00:00:00

  • Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells.

    abstract::Beta-L-(-)-dioxolane cytidine [(-)-OddC] is the first nucleoside analogue with the unnatural L configuration shown to have anticancer activity. The transport and metabolism of this unique compound were studied in human prostate carcinoma DU-145 cells. (-)-OddC was translocated rapidly into the cells by both equilibrat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Grove KL,Cheng YC

    更新日期:1996-09-15 00:00:00

  • Tumor-immunotherapeutic efficacy of Serratia marcescens polyribosomes.

    abstract::The ability of polyribosomes, obtained from several bacterial species, to suppress the development of cutaneous SaD2 fibrosarcomas in DBA/2 mice were evaluated. Suppression of tumor appearance depended upon the tumor load at the time of treatment, dose of polyribosomes, and species source of polyribosomes, with Serrat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Urban RW,Edwards BS,Segal W

    更新日期:1980-05-01 00:00:00

  • The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.

    abstract::This report describes and presents some preliminary results from a prospective clinical investigation to determine the ablative effect of thiotepa (N,N',N''-triethylene phosphoramide) on superficial low-stage bladder cancer and the effectiveness of this agent in the prevention of recurrent or new tumors. In the small ...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors:

    更新日期:1977-08-01 00:00:00

  • Serological markers of cancer and their applications in clinical trials.

    abstract::Strategies for the prevention of cancer include those aimed at reducing the incidence of cancer (primary prevention) and cancer mortality through early detection of tumors (secondary prevention). The efficacy of prevention interventions is evaluated by clinical trials. The conduct of clinical trials is aided by the us...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Helzlsouer KJ

    更新日期:1994-04-01 00:00:00

  • Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.

    abstract::BAG-1 is a multifunctional protein that blocks apoptosis and interacts with several types of proteins, including Bcl-2 family proteins, the kinase Raf-1, certain tyrosine kinase growth factor receptors, and steroid hormone receptors, possibly by virtue of its ability to regulate the Hsp70/Hsc70 family of molecular cha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takayama S,Krajewski S,Krajewska M,Kitada S,Zapata JM,Kochel K,Knee D,Scudiero D,Tudor G,Miller GJ,Miyashita T,Yamada M,Reed JC

    更新日期:1998-07-15 00:00:00

  • Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.

    abstract::A total of 224 chemicals that have been tested in long-term studies for carcinogenicity in rats and mice by the National Cancer Institute and the National Toxicology Program were tested for mutagenicity in Salmonella typhimurium. Correlations between mutagenicity and carcinogenicity were examined. The influences of ch...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zeiger E

    更新日期:1987-03-01 00:00:00

  • Influence of pH on the thermal sensitivity of cultured human glioblastoma cells.

    abstract::The hyperthermic sensitivity of cultured human glioblastoma cells was determined in 1 degree increments from 42 through 46 degrees over the pH range of 6.1 to 7.4. These cells were 5 to 10 times less heat sensitive than were Chinese hamster ovary cells and are among the most resistant cells examined in cell culture. A...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gerweck LE,Richards B

    更新日期:1981-03-01 00:00:00

  • A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene.

    abstract::3q27 translocations affecting the BCL6 gene can involve not only immunoglobulin genes (IG) but also other as yet uncharacterized chromosomal loci as partners. Here, we describe cloning of the junctional area of a recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma of B-cell type and isolation of clones...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Akasaka T,Miura I,Takahashi N,Akasaka H,Yonetani N,Ohno H,Fukuhara S,Okuma M

    更新日期:1997-01-01 00:00:00

  • Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines.

    abstract::To identify mechanisms of camptothecin (CPT) resistance/toxicity, sublines from a human KB cell line were made resistant to CPT by continuous selection in increasing concentrations of CPT. Two CPT-resistant lines, 100 and 300, were 32- and 54-fold resistant to the growth-inhibitory properties of CPT compared to the KB...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Beidler DR,Chang JY,Zhou BS,Cheng YC

    更新日期:1996-01-15 00:00:00

  • A systematic profile of DNA methylation in human cancer cell lines.

    abstract::Human cancer cell lines are commonly used in basic cancer research to understand the behavior of primary tumors. Aberrations in the DNA methylation patterns are nowadays recognized as a hallmark of the cancer cell. However, no comprehensive study defines the DNA methylation environment present in the established cance...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Paz MF,Fraga MF,Avila S,Guo M,Pollan M,Herman JG,Esteller M

    更新日期:2003-03-01 00:00:00

  • A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling.

    abstract::The sodium iodide symporter (NIS) is a classical iodide pump typically localized within the cell plasma membrane in thyroid cells, where NIS expression is believed to ensure success of mainstay radioiodide therapy in thyroid cancers. Although radioiodide uptake is generally reduced in thyroid cancer tissue, intracellu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1954

    authors: Feng F,Yehia L,Ni Y,Chang YS,Jhiang SM,Eng C

    更新日期:2018-11-01 00:00:00

  • DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II.

    abstract::The Chinese hamster ovary cell line xrs-1 is hypersensitive to gamma-radiation. This sensitivity has been attributed to an inability of this cell line to efficiently repair gamma-ray induced double-strand breaks (DSBs). We have recently reported that xrs-1 is also sensitive to topoisomerase II inhibitors that stabiliz...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Caldecott K,Banks G,Jeggo P

    更新日期:1990-09-15 00:00:00

  • Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.

    abstract::CPT-11 [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin ] is a prodrug that is converted to the active metabolite SN-38 by carboxylesterases. In its active form, the drug inhibits topoisomerase I, causes DNA damage, and induces apoptosis. Data in this study show metabolism of CPT-11 to SN-38 (7-ethyl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Danks MK,Morton CL,Pawlik CA,Potter PM

    更新日期:1998-01-01 00:00:00

  • EGF816 Exerts Anticancer Effects in Non-Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor.

    abstract::Non-small cell lung cancer patients carrying oncogenic EGFR mutations initially respond to EGFR-targeted therapy, but later elicit minimal response due to dose-limiting toxicities and acquired resistance. EGF816 is a novel, irreversible mutant-selective EGFR inhibitor that specifically targets EGFR-activating mutation...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2581

    authors: Jia Y,Juarez J,Li J,Manuia M,Niederst MJ,Tompkins C,Timple N,Vaillancourt MT,Pferdekamper AC,Lockerman EL,Li C,Anderson J,Costa C,Liao D,Murphy E,DiDonato M,Bursulaya B,Lelais G,Barretina J,McNeill M,Epple R,Mar

    更新日期:2016-03-15 00:00:00

  • Proteomic portrait of human breast cancer progression identifies novel prognostic markers.

    abstract::Breast cancer is the second leading cause of cancer death for women in the United States. Of the different subtypes, estrogen receptor-negative (ER(-)) tumors, which are ErbB2+ or triple-negative, carry a relatively poor prognosis. In this study, we used system-wide analysis of breast cancer proteomes to identify prot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3711

    authors: Geiger T,Madden SF,Gallagher WM,Cox J,Mann M

    更新日期:2012-05-01 00:00:00

  • EZH2 is essential for glioblastoma cancer stem cell maintenance.

    abstract::Overexpression of the polycomb group protein enhancer of zeste homologue 2 (EZH2) occurs in diverse malignancies, including prostate cancer, breast cancer, and glioblastoma multiforme (GBM). Based on its ability to modulate transcription of key genes implicated in cell cycle control, DNA repair, and cell differentiati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1622

    authors: Suvà ML,Riggi N,Janiszewska M,Radovanovic I,Provero P,Stehle JC,Baumer K,Le Bitoux MA,Marino D,Cironi L,Marquez VE,Clément V,Stamenkovic I

    更新日期:2009-12-15 00:00:00

  • Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

    abstract::Adrenocortical carcinoma (ACC) is a rare disease with an overall poor but heterogeneous prognosis. This heterogeneity could reflect different mechanisms of tumor development. Gene expression profiling by transcriptome analysis led to ACC being divided into two groups of tumors with very different outcomes. Somatic ina...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2014

    authors: Ragazzon B,Libé R,Gaujoux S,Assié G,Fratticci A,Launay P,Clauser E,Bertagna X,Tissier F,de Reyniès A,Bertherat J

    更新日期:2010-11-01 00:00:00

  • Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).

    abstract::Neuroblastoma (NB) arises from primitive sympathetic neuroblasts in the adrenal gland or the sympathetic ganglion. NB in situ, sometimes observed in the adrenal glands of autopsied infants, is considered to be a premalignant lesion that may develop into NB. Little is understood about the morphological and biochemical ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matsumura T,Sugimoto T,Sawada T,Amagai T,Negoro S,Kemshead JT

    更新日期:1987-06-01 00:00:00

  • Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver.

    abstract::The effects of chemical carcinogenesis to produce premalignant hyperplastic nodules in rat liver on concomitant immune function were studied. Induction of hyperplastic nodules in Fischer rats was accomplished using a combined regimen of diethylnitrosamine, 2-acetylaminofluorene, and partial hepatectomy. Hyperplastic n...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Leu RW,Norton TR,Herriott MJ,Ringer DP,Kearns RJ

    更新日期:1985-07-01 00:00:00

  • Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.

    abstract::We evaluated whether treatment of orthotopic human prostate cancer in nude mice with pegylated IFN-alpha-2b (PEG-IFN-alpha-2b) and docetaxel could represent a two-compartment targeting of primary tumor (tumor cells and tumor-associated endothelial cells) and inhibition of regional lymph node metastasis. The antiangiog...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huang SF,Kim SJ,Lee AT,Karashima T,Bucana C,Kedar D,Sweeney P,Mian B,Fan D,Shepherd D,Fidler IJ,Dinney CP,Killion JJ

    更新日期:2002-10-15 00:00:00

  • Dose response of hepatocyte replication in rats following continuous exposure to diethylnitrosamine.

    abstract::Chronic exposure to the hepatocellular carcinogen diethylnitrosamine (DEN) causes a dose-dependent accumulation of the promutagenic DNA adduct O4-ethyldeoxythymidine in hepatocytes and increases in the number of initiated hepatocytes as indicated by gamma-glutamyl transpeptidase positive foci. Initiation is thought to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Deal FH,Richardson FC,Swenberg JA

    更新日期:1989-12-15 00:00:00

  • Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.

    abstract::Prostate cancer stem-like cells (PCSLC) are believed to be responsible for prostate cancer onset and metastasis. Autocrine and microenvironmental signals dictate PCSLC behavior and patient outcome. In prostate cancer patients, IL30/IL27p28 has been linked with tumor progression, but the mechanisms underlying this link...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3117

    authors: Sorrentino C,Ciummo SL,Cipollone G,Caputo S,Bellone M,Di Carlo E

    更新日期:2018-05-15 00:00:00

  • Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma.

    abstract::Head and neck squamous cell carcinomas (HNSCC) often metastasize to locoregional lymph nodes, and lymph node involvement represents one of the most important prognostic factors of poor clinical outcome. HNSCCs are remarkably lymphangiogenic and represent a clear example of a cancer that utilizes the lymphatic vasculat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3121

    authors: Doçi CL,Mikelis CM,Lionakis MS,Molinolo AA,Gutkind JS

    更新日期:2015-07-15 00:00:00